Factors affecting surgical decision-making in carriers of BRCA1/2 pathogenic variants undergoing risk-reducing surgery at a dedicated hereditary ovarian cancer clinic
Conclusion:
Women with BRCA1/2 pathogenic variants face challenging decisions regarding risk reduction and care providers must be knowledgeable and supportive in helping women make informed and individualized choices about their care.
Video Summary:http://links.lww.com/MENO/A857.
Source: Menopause - Category: OBGYN Tags: Original Studies Source Type: research
More News: Canada Health | Cancer | Cancer & Oncology | Endometrial Cancer | Fallopian Tube Cancer | Hysterectomy | Men | Menopause | OBGYN | Ovarian Cancer | Ovaries | Pathology | Reproduction Medicine | Study | Tamoxifen | Women